Log In
BCIQ
Print this Print this
 

ITCA 884

  Manage Alerts
Collapse Summary General Information
Company Intarcia Therapeutics Inc.
DescriptionWeight regulatory endocrine peptide delivered with Duros technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today